Nils Mauritzson

987 total citations
18 papers, 719 citations indexed

About

Nils Mauritzson is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Nils Mauritzson has authored 18 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 8 papers in Public Health, Environmental and Occupational Health and 7 papers in Molecular Biology. Recurrent topics in Nils Mauritzson's work include Acute Myeloid Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (8 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Nils Mauritzson is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (8 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Nils Mauritzson collaborates with scholars based in Sweden, United States and Germany. Nils Mauritzson's co-authors include Lars Hagmar, María Albin, Bertil Johansson, Ulf Strömberg, Felix Mitelman, Jonas Björk, Rolf Billström, Zoli Mikoczy, Tomas Ahlgren and Lars Rylander and has published in prestigious journals such as Journal of Cellular Physiology, British Journal of Haematology and Epidemiology.

In The Last Decade

Nils Mauritzson

18 papers receiving 698 citations

Peers

Nils Mauritzson

HEMAT

GENET

PHEOH

Annika Dufour Germany

MR Baer United States

Kerstin Görlich Germany

Emiliano Fabiani Italy

Ilaria Ambaglio Italy

Haiyang Yun Germany

O. Krieger Austria

Nobuo Oguma Japan

Samuel Kopel United States

Arjan van de Loosdrecht Netherlands

Annika Dufour Germany

Nils Mauritzson

656 ×1.1

HEMAT

414 ×1.5

253 ×1.0

GENET

154 ×0.7

PHEOH

128 ×1.6

Citations per year, relative to Nils Mauritzson Nils Mauritzson (= 1×) peers Annika Dufour

Countries citing papers authored by Nils Mauritzson

Since Specialization

Citations

This map shows the geographic impact of Nils Mauritzson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nils Mauritzson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nils Mauritzson more than expected).

Fields of papers citing papers by Nils Mauritzson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nils Mauritzson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nils Mauritzson. The network helps show where Nils Mauritzson may publish in the future.

Co-authorship network of co-authors of Nils Mauritzson

This figure shows the co-authorship network connecting the top 25 collaborators of Nils Mauritzson. A scholar is included among the top collaborators of Nils Mauritzson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nils Mauritzson. Nils Mauritzson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Palmblad, Jan, Magnus Björkholm, Jack Kutti, et al.. (2008). TPO, but not soluble-IL-6 receptor, levels increase after anagrelide treatment of thrombocythemia in chronic myeloproliferative disorders. International Journal of Medical Sciences. 5(2). 87–91. 6 indexed citations

Daskalakis, Michael, Nils Mauritzson, Bertil Johansson, et al.. (2006). Trisomy 19 as the sole chromosomal abnormality in proliferative chronic myelomonocytic leukemia. Leukemia Research. 30(8). 1043–1047. 6 indexed citations

Albin, María, Jonas Björk, Hans Welinder, et al.. (2003). Cytogenetic and morphologic subgroups of myelodysplastic syndromes in relation to occupational and hobby exposures. Scandinavian Journal of Work Environment & Health. 29(5). 378–387. 9 indexed citations

Paulsson, Kajsa, Thoas Fioretos, Bodil Strömbeck, et al.. (2003). Trisomy 8 as the sole chromosomal aberration in myelocytic malignancies. Cancer Genetics and Cytogenetics. 140(1). 66–69. 20 indexed citations

Andersen, Mette Klarskov, Richard A. Larson, Nils Mauritzson, et al.. (2002). Balanced chromosome abnormalities inv(16) and t(15;17) in therapy‐related myelodysplastic syndromes and acute leukemia: Report from an International Workshop†. Genes Chromosomes and Cancer. 33(4). 395–400. 99 indexed citations

Merup, Mats, Jack Kutti, Nils Mauritzson, et al.. (2002). Negligible Clinical Effects of Thalidomide in Patients with Myelofibrosis with Myeloid Metaplasia. Medical Oncology. 19(2). 79–86. 32 indexed citations

Barbouti, Aikaterini, Bertil Johansson, Mattias Höglund, et al.. (2002). Multicolor COBRA‐FISH analysis of chronic myeloid leukemia reveals novel cryptic balanced translocations during disease progression. Genes Chromosomes and Cancer. 35(2). 127–137. 19 indexed citations

Mauritzson, Nils, María Albin, Lars Rylander, et al.. (2002). Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976–1993 and on 5098 unselected cases reported in the literature 1974–2001. Leukemia. 16(12). 2366–2378. 175 indexed citations

Björk, Jonas, María Albin, Hans Welinder, et al.. (2001). Are occupational, hobby, or lifestyle exposures associated with Philadelphia chromosome positive chronic myeloid leukaemia?. Occupational and Environmental Medicine. 58(11). 722–727. 35 indexed citations

10.

Björk, Jonas, María Albin, Nils Mauritzson, et al.. (2001). Smoking and acute myeloid leukemia: associations with morphology and karyotypic patterns and evaluation of dose–response relations. Leukemia Research. 25(10). 865–872. 35 indexed citations

11.

Mauritzson, Nils, B Johansson, Lars Rylander, et al.. (2001). The prognostic impact of karyotypic subgroups in myelodysplastic syndromes is strongly modified by sex. British Journal of Haematology. 113(2). 347–356. 25 indexed citations

12.

Albin, María, Jonas Björk, Hans Welinder, et al.. (2000). Acute myeloid leukemia and clonal chromosome aberrations in relation to past exposure to organic solvents. Scandinavian Journal of Work Environment & Health. 26(6). 482–491. 27 indexed citations

13.

Björk, Jonas, María Albin, Nils Mauritzson, et al.. (2000). Smoking and Myelodysplastic Syndromes. Epidemiology. 11(3). 285–291. 58 indexed citations

14.

Mauritzson, Nils, B Johansson, María Albin, et al.. (2000). Survival time in a population-based consecutive series of adult acute myeloid leukemia – the prognostic impact of karyotype during the time period 1976–1993. Leukemia. 14(6). 1039–1043. 15 indexed citations

15.

Mauritzson, Nils, Bertil Johansson, María Albin, et al.. (1999). A single‐center population‐based consecutive series of 1500 cytogenetically investigated adult hematological malignancies: karyotypic features in relation to morphology, age and gender. European Journal Of Haematology. 62(2). 95–102. 54 indexed citations

16.

Mauritzson, Nils, et al.. (1996). Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders.. PubMed. 81(11). 245–52. 80 indexed citations

17.

Johansson, Bertil, Rolf Billström, Nils Mauritzson, & Felix Mitelman. (1994). Trisomy 19 as the sole chromosomal anomaly in hematologic neoplasms. Cancer Genetics and Cytogenetics. 74(1). 62–65. 22 indexed citations

18.

Bar‐Eli, Menashe, et al.. (1982). Insertion of drug resistance genes in animals. Journal of Cellular Physiology. 113(S1). 213–217. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact